Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 68 results:
Συντάκτης [ Τίτλος(Asc)] Τύπος Έτος
Φίλτρα: Συντάκτης is Sarafidis, Pantelis  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
Zoccali, C., Vanholder R., Massy Z. A., Ortiz A., Sarafidis P., Dekker F. W., et al. (2017).  The systemic nature of CKD.. Nat Rev Nephrol. 13(6), 344-358.
Saratzis, A., Sarafidis P., Melas N., Hunter J. P., Saratzis N., Kiskinis D., et al. (2012).  Suprarenal graft fixation in endovascular abdominal aortic aneurysm repair is associated with a decrease in renal function.. J Vasc Surg. 56(3), 594-600.
Malindretos, P., Sarafidis P., Lazaridis A., & Nikolaidis P. (2012).  A study of the association of higher parathormone levels with health-related quality of life in hemodialysis patients.. Clin Nephrol. 77(3), 196-203.
Memmos, E., Sarafidis P., Pateinakis P., Tsiantoulas A., Faitatzidou D., Giamalis P., et al. (2019).  Soluble Klotho is associated with mortality and cardiovascular events in hemodialysis.. BMC Nephrol. 20(1), 217.
Sarafidis, P., & Papagianni A. (2019).  Sodium-Glucose Cotransporter-2 Inhibitors and Urinary Tract Infections.. Ann Intern Med. 171(12), 943-944.
Tsioufis, C., Andrikou I., Pruijm M., Ponte B., Sarafidis P., Koureas A., et al. (2018).  Should renal color Doppler ultrasonography be a routine test in newly diagnosed hypertensive patient?. J Hypertens. 36(1), 16-22.
Sarafidis, P., Loutradis C., Ferro C. J., & Ortiz A. (2020).  SGLT-2 Inhibitors to Treat Hyponatremia Associated with SIADH: A Novel Indication?. Am J Nephrol. 51(7), 553-555.
Fernandez-Fernandez, B., Sarafidis P., Kanbay M., Navarro-González J. F., Soler M. José, Gorriz J. Luis, et al. (2020).  SGLT2 inhibitors for non-diabetic kidney disease: drugs to treat CKD that also improve glycaemia.. Clin Kidney J. 13(5), 728-733.
Piperidou, A., Loutradis C., & Sarafidis P. (2020).  SGLT-2 inhibitors and nephroprotection: current evidence and future perspectives.. J Hum Hypertens.
Sarafidis, P., Ferro C. J., Morales E., Ortiz A., Malyszko J., Hojs R., et al. (2019).  SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA.. Nephrol Dial Transplant. 34(2), 208-230.
Sarafidis, P., Ferro C. J., Morales E., Ortiz A., Malyszko J., Hojs R., et al. (2020).  SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA.. Nephrol Dial Transplant. 35(10), 1825.
Sampani, E., Sarafidis P., Dimitriadis C., Kasimatis E., Daikidou D., Bantis K., et al. (2020).  Severe euglycemic diabetic ketoacidosis of multifactorial etiology in a type 2 diabetic patient treated with empagliflozin: case report and literature review.. BMC Nephrol. 21(1), 276.
Drosos, G., Ampatzidou F., Sarafidis P., Karaiskos T., Madesis A., & Boutou A. K. (2018).  Serum Creatinine and Chronic Kidney Disease-Epidemiology Estimated Glomerular Filtration Rate: Independent Predictors of Renal Replacement Therapy following Cardiac Surgery.. Am J Nephrol. 48(2), 108-117.
Dimitroulas, T., Sarafidis P., Roma V., Karagiannopoulou G., Kapoulas S., Dimitroula H., et al. (2010).  Scleroderma renal crisis accompanied by new-onset pulmonary arterial hypertension: an acute systemic endothelial injury? Case report and literature.. Inflamm Allergy Drug Targets. 9(4), 313-8.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.